5 Analysts Assess CareDx: What You Need To Know
Portfolio Pulse from Benzinga Insights
Over the past three months, five analysts have evaluated CareDx (NASDAQ:CDNA), with a majority expressing bullish sentiments. The average 12-month price target has increased significantly to $32.2, indicating positive expectations. Analysts have adjusted their ratings and price targets, reflecting a favorable outlook for CareDx's market performance.
October 16, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CareDx has received predominantly bullish analyst ratings, with a significant increase in the average 12-month price target to $32.2. This reflects positive market sentiment and expectations for the company's future performance.
The majority of analysts have given CareDx a bullish rating, and the average price target has increased significantly, suggesting a positive outlook for the stock. This is likely to boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100